Tumour studies in both affected individuals supported the primary tumourigenic role of the SDHA variant with histology typical of SDH deficiency, loss of SDHB immunostaining (which indicates loss of a SDH complex component and is an indirect measure of SDHA loss) and evidence for loss of the wild-type SDHA allele on somatic sequencing. The gene discussed is SDHB; the disease is neoplasm.